Inventor · disambiguated record
Stephen D. Gillies
Also filed as: GILLIES STEPHEN · GILLIES STEPHEN D · GILLIES STEPHEN DOUGLAS
75 granted patents·34 pending applications·3,172 citations·filing 1984–2024
99Inventor score
Files withMERCK PATENT GMBH32EMD LEXIGEN RES CT CORP18KYMAB LTD14GILLIES STEPHEN D9ABBOTT BIOTECH INC4
Top patents by PatentIndex Score
109 records- 0199US6617135B1Multiple cytokine protein complexesEMD LEXIGEN RES CT CORP·Filed 2000·Granted Sep 9, 2003·211 cites·17 claims
- 0298US7186804B2IL-2 fusion proteins with modulated selectivityEMD LEXIGEN RES CT CORP·Filed 2002·Granted Mar 6, 2007·140 cites·23 claims
- 0398US7148321B2Expression technology for proteins containing a hybrid isotype antibody moietyEMD LEXIGEN RES CT CORP·Filed 2002·Granted Dec 12, 2006·114 cites·10 claims
- 0498US7091321B2Enhancing the circulating half-life of antibody-based fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2001·Granted Aug 15, 2006·133 cites·31 claims
- 0598US6992174B2Reducing the immunogenicity of fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2002·Granted Jan 31, 2006·94 cites·2 claims
- 0697US9617338B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Apr 11, 2017·78 cites·20 claims
- 0797US9567399B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Feb 14, 2017·96 cites·21 claims
- 0897US7888071B2DNA encoding IL-2 fusion proteins with modulated selectivityMERCK PATENT GMBH·Filed 2008·Granted Feb 15, 2011·48 cites·26 claims
- 0997US7790415B2Enhancing the circulating half-life of antibody-based fusion proteinsMERCK PATENT GMBH·Filed 2009·Granted Sep 7, 2010·43 cites·42 claims
- 1097US7067110B1Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigensEMD LEXIGEN RES CT CORP·Filed 2000·Granted Jun 27, 2006·110 cites·25 claims
- 1197US5726044AExpression and export technology of proteins as immunofusinsFUJI IMMUNOPHARMACEUTICALS COR·Filed 1995·Granted Mar 10, 1998·259 cites·8 claims
- 1297US5650150ARecombinant antibody cytokine fusion proteinsFiled 1994·Granted Jul 22, 1997·206 cites·21 claims
- 1397US5541087AExpression and export technology of proteins as immunofusinsFUJI IMMUNOPHARMACEUTICALS COR·Filed 1994·Granted Jul 30, 1996·463 cites·12 claims
- 1496US10604576B2Antibodies and immunocytokinesKYMAB LTD·Filed 2017·Granted Mar 31, 2020·25 cites·14 claims
- 1596US9957323B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted May 1, 2018·27 cites·26 claims
- 1696US7670595B2Fc-interferon-beta fusion proteinsMERCK PATENT GMBH·Filed 2005·Granted Mar 2, 2010·54 cites·16 claims
- 1796US7507406B2Enhancing the circulating half-life of antibody-based fusion proteinsEMD SERONO RES CT INC·Filed 2005·Granted Mar 24, 2009·49 cites·20 claims
- 1896US7169904B2Immunocytokine sequences and uses thereofEMD LEXIGEN RES CT CORP·Filed 2003·Granted Jan 30, 2007·46 cites·5 claims
- 1996US6838260B2Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulationEMD LEXIGEN RES CT CORP·Filed 2001·Granted Jan 4, 2005·78 cites·8 claims
- 2095US8066994B2Proteins comprising an IgG2 domainGILLIES STEPHEN D·Filed 2006·Granted Nov 29, 2011·25 cites·13 claims
- 2195US7955590B2Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigensMERCK PATENT GMBH·Filed 2005·Granted Jun 7, 2011·40 cites·68 claims
- 2295US7767405B2Immunocytokine sequences and uses thereofMERCK PATENT GMBH·Filed 2006·Granted Aug 3, 2010·25 cites·4 claims
- 2395US7589179B2IL-7 variants with reduced immunogenicityMERCK PATENT GMBH·Filed 2005·Granted Sep 15, 2009·40 cites·8 claims
- 2495US7462350B2Cancer treatments including administering IL-2 fusion proteins with modulated selectivityEMD SERONO RES CT INC·Filed 2006·Granted Dec 9, 2008·34 cites·4 claims
- 2594US7226998B2Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulationEMD LEXIGEN RES CT CORP·Filed 2004·Granted Jun 5, 2007·35 cites·8 claims
- 2694US7141651B2Multiple cytokine protein complexesEMD LEXIGEN RES CT CORP·Filed 2003·Granted Nov 28, 2006·50 cites·29 claims
- 2794US6969517B2Recombinant tumor specific antibody and use thereofEMD LEXIGEN RES CT CORP·Filed 2002·Granted Nov 29, 2005·54 cites·5 claims
- 2893US8337844B2CD20-binding polypeptide compositions for treating autoimmune diseaseCARR FRANCIS JOSEPH·Filed 2012·Granted Dec 25, 2012·25 cites·19 claims
- 2993US7576193B2Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulationMERCK PATENT GMBH·Filed 2007·Granted Aug 18, 2009·11 cites·8 claims
- 3093US7432357B2Anti-cancer antibodies with reduced complement fixationMERCK PATENT GMBH·Filed 2005·Granted Oct 7, 2008·16 cites·3 claims
- 3192US7601814B2Reducing the immunogenicity of fusion proteinsMERCK PATENT GMBH·Filed 2005·Granted Oct 13, 2009·10 cites·7 claims
- 3292US7582288B2Methods of targeting multiple cytokinesMERCK PATENT GMBH·Filed 2006·Granted Sep 1, 2009·14 cites·6 claims
- 3392US7323549B2IL-7 fusion proteinsEMD LEXIGEN RES CT CORP·Filed 2004·Granted Jan 29, 2008·50 cites·17 claims
- 3491US9617349B2Anti-cancer antibodies with reduced complement fixationMERCK PATENT GMBH·Filed 2014·Granted Apr 11, 2017·9 cites·14 claims
- 3591US7960514B2IL-7 fusion proteinsMERCK PATENT GMBH·Filed 2007·Granted Jun 14, 2011·17 cites·20 claims
- 3691US7189830B2Anti-KSA/IL-2 fusion proteins with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Mar 13, 2007·29 cites·1 claims
- 3790US10633452B2Anti-cancer antibodies with reduced complement fixationMERCK PATENT GMBH·Filed 2018·Granted Apr 28, 2020·2 cites·10 claims
- 3890US8043608B2Methods of using Fc-cytokine fusion proteinsMERCK PATENT GMBH·Filed 2009·Granted Oct 25, 2011·13 cites·6 claims
- 3990US6384032B1Inhibitors of IL-12 productionSHIONOGI BIORES CORP·Filed 2000·Granted May 7, 2002·63 cites·36 claims
- 4089US8835606B2Anti-cancer antibodies with reduced complement fixationGILLIES STEPHEN D·Filed 2008·Granted Sep 16, 2014·8 cites·7 claims
- 4189US8147832B2CD20-binding polypeptide compositions and methodsCARR FRANCIS JOSEPH·Filed 2004·Granted Apr 3, 2012·33 cites·19 claims
- 4289US7879319B2Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulationMERCK PATENT GMBH·Filed 2009·Granted Feb 1, 2011·8 cites·3 claims
- 4388US12209128B2Anti-PD-L1 antibodiesKYMAB LTD·Filed 2021·Granted Jan 28, 2025·1 cites·6 claims
- 4488US11965026B2Anti-PD-L1 and IL-2 cytokinesKYMAB LTD·Filed 2017·Granted Apr 23, 2024·3 cites·19 claims
- 4587US7365054B2Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapiesSCRIPPS RESEARCH INST·Filed 2006·Granted Apr 29, 2008·9 cites·5 claims
- 4687US4663281AEnhanced production of proteinaceous materials in eucaryotic cellsMASSACHUSETTS INST TECHNOLOGY·Filed 1984·Granted May 5, 1987·61 cites·25 claims
- 4786US7465447B2Fc-erythropoietin fusion protein with improved pharmacokineticsMERCK PATENT GMBH·Filed 2004·Granted Dec 16, 2008·23 cites·4 claims
- 4886US7459538B2Recombinant tumor specific antibody and use thereofMERCK PATENT GMBH·Filed 2005·Granted Dec 2, 2008·7 cites·16 claims
- 4985US10603367B2Humanized antibodiesPROBIODRUG AG·Filed 2018·Granted Mar 31, 2020·2 cites·18 claims
- 5085US8338575B2IL-7 fusion proteinsLAUDER SCOTT·Filed 2011·Granted Dec 25, 2012·12 cites·19 claims
Showing the top 50 of 109 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen D. Gillies files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →